{"url_path":"/sec/ibio/8-k/2026-05-08/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 ****Regulation FD Disclosure****.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1420720/0001104659-26-057945-index.html","accession_number":"0001104659-26-057945","cik":"0001420720","ticker":"IBIO","issuer_name":"iBio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1420720/0001104659-26-057945-index.html","primary_entity_key":"0001420720","primary_entity_name":"iBio, Inc."},"word_count":138,"has_tables":true,"body_markdown":"**Item 7.01****Regulation FD Disclosure****.**\n\n​\n\nOn May 8, 2026, the Company issued a press release, a copy of which is filed herewith as Exhibit 99.1, announcing the appointment of Dr. Stoner. The information set forth in this Item 7.01 and in Exhibit 99.1 is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Item 7.01 and in Exhibit 99.1 shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.\n\n​\n\n​"}